[go: up one dir, main page]

PE20160850A1 - Sistema multiparticulado para administrar drogas - Google Patents

Sistema multiparticulado para administrar drogas

Info

Publication number
PE20160850A1
PE20160850A1 PE2016000631A PE2016000631A PE20160850A1 PE 20160850 A1 PE20160850 A1 PE 20160850A1 PE 2016000631 A PE2016000631 A PE 2016000631A PE 2016000631 A PE2016000631 A PE 2016000631A PE 20160850 A1 PE20160850 A1 PE 20160850A1
Authority
PE
Peru
Prior art keywords
microgel particles
administering drugs
multiparticulate system
multiparticulate
carrageenans
Prior art date
Application number
PE2016000631A
Other languages
English (en)
Inventor
Gonzalez Roberto Carlos Bravo
Felipe Jose Oliveira Varum
Martin Thomas Kuentz
Kruif Jan Kendall De
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of PE20160850A1 publication Critical patent/PE20160850A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se refiere a un sistema multiparticulado para administrar drogas que comprende particulas de microgel que contienen un ingrediente farmaceutico activo, donde las particulas de microgel han de ser dispersadas en una composicion liquida no acuosa. Las particulas de microgel contienen al menos un polimero formador de geles tal como quitosano, acidos poliacrilicos, alginatos, carrageninas, entre otros
PE2016000631A 2013-11-13 2014-11-13 Sistema multiparticulado para administrar drogas PE20160850A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13192657 2013-11-13
EP14157427 2014-03-03

Publications (1)

Publication Number Publication Date
PE20160850A1 true PE20160850A1 (es) 2016-09-23

Family

ID=51900424

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2016000631A PE20160850A1 (es) 2013-11-13 2014-11-13 Sistema multiparticulado para administrar drogas

Country Status (19)

Country Link
US (1) US20160287521A1 (es)
EP (1) EP3068381B1 (es)
JP (2) JP2016537352A (es)
KR (1) KR20160085269A (es)
CN (1) CN105899197A (es)
AU (1) AU2014350208B2 (es)
CA (1) CA2930277A1 (es)
CL (1) CL2016001148A1 (es)
CR (1) CR20160263A (es)
CU (1) CU20160069A7 (es)
EA (1) EA201600387A1 (es)
HK (1) HK1224219A1 (es)
MD (1) MD20160061A2 (es)
MX (1) MX2016006275A (es)
NZ (1) NZ720512A (es)
PE (1) PE20160850A1 (es)
PH (1) PH12016500847A1 (es)
TN (1) TN2016000160A1 (es)
WO (1) WO2015071366A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11510877B2 (en) 2017-10-10 2022-11-29 Capsugel Belgium Nv Gelling multiparticulates
EP3636752A4 (en) 2018-07-25 2021-04-28 Alteogen, Inc. NEW HYALURONIC ACID HYDROLYZING ENZYMUTANTS AND THE PHARMACEUTICAL COMPOSITION CONTAINING THIS
KR102154565B1 (ko) * 2018-11-13 2020-09-10 한국화학연구원 천연 오일을 함유하는 미세캡슐 및 이의 제조방법
CN111388759B (zh) * 2020-04-28 2021-09-07 四川大学 一种骨水泥复合材料及其制备方法
JP7622088B2 (ja) 2020-08-07 2025-01-27 アルテオジェン・インコーポレイテッド 組換えヒアルロニダーゼの生産方法
JPWO2024101250A1 (es) * 2022-11-11 2024-05-16
KR102847026B1 (ko) * 2023-08-25 2025-08-18 에바바이오 주식회사 프릴링 방법을 적용하여 제조한 다중소포성 리포좀의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657653B2 (ja) * 1985-08-23 1994-08-03 藤沢薬品工業株式会社 油性懸濁型直腸注入剤
DK0531497T3 (da) * 1991-04-02 1998-03-23 Biotech Australia Pty Ltd Orale indgivelsessystemer til mikropartikler
US5879712A (en) * 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
FR2754177B1 (fr) * 1996-10-07 1999-08-06 Sanofi Sa Microspheres pharmaceutiques d'acide valproique pour administration orale
EP1616562A1 (en) * 1999-06-07 2006-01-18 ALTANA Pharma AG Novel preparation and administration form comprising an acid-labile active compound
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP4046313B2 (ja) * 2001-01-12 2008-02-13 株式会社資生堂 油中水型乳化組成物およびこれを用いた乳化化粧料
US7993749B2 (en) * 2005-12-16 2011-08-09 University Of Kansas Nanoparticles comprising a nanoparticle template and a polymer shell having an amide side chain, and method of making thereof
CA2633380A1 (en) * 2005-12-16 2007-07-05 University Of Kansas Nanoclusters for delivery of therapeutics
PT103476B (pt) * 2006-05-10 2008-09-19 Univ De Coimbra Processo de produção e isolamento de micro- e nanopartículas poliméricas contendo macromoléculas de natureza hidrofílica e termolábil
EP2217363B1 (en) * 2007-11-14 2018-09-19 The University Of Queensland Method and use of a device for preparing microparticles
EP2111854A1 (en) * 2008-04-22 2009-10-28 Lek Pharmaceuticals D.D. Self-microemulsifying systems incorporated into liquid core microcapsules

Also Published As

Publication number Publication date
CU20160069A7 (es) 2016-10-28
EA201600387A1 (ru) 2016-08-31
CA2930277A1 (en) 2015-05-21
NZ720512A (en) 2018-01-26
EP3068381A1 (en) 2016-09-21
KR20160085269A (ko) 2016-07-15
PH12016500847A1 (en) 2016-06-20
CN105899197A (zh) 2016-08-24
CL2016001148A1 (es) 2016-11-25
WO2015071366A1 (en) 2015-05-21
HK1224219A1 (zh) 2017-08-18
MX2016006275A (es) 2017-01-05
MD20160061A2 (ro) 2016-10-31
CR20160263A (es) 2017-04-05
JP2019112413A (ja) 2019-07-11
AU2014350208A1 (en) 2016-06-16
JP2016537352A (ja) 2016-12-01
US20160287521A1 (en) 2016-10-06
TN2016000160A1 (en) 2017-10-06
AU2014350208B2 (en) 2017-09-07
EP3068381B1 (en) 2019-09-11

Similar Documents

Publication Publication Date Title
PE20160850A1 (es) Sistema multiparticulado para administrar drogas
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
WO2015095624A3 (en) Drug mixing and delivery system and method
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
UY35907A (es) Nuevas indazolcarboxamidas, procedimientos para su preparación, preparaciones farmaceuticas que las contienen, así como su uso para la preparación de medicamentos
MX2018003096A (es) Composicion farmaceutica que contiene farmaco anionico, y metodo de preparacion para la misma.
FI20116138A7 (fi) Matriisi bioaktiivisten aineiden hallittuun vapauttamiseen
EP3072506A4 (en) Carrier for drug delivery and conjugate, composition containing same, and method for administering same
MX2016005395A (es) Formulacion estable de insulina glulisina.
PH12015502755A1 (en) Insulin glargine / lixisenatide fixed ratio formulation
BR112016006171A2 (pt) formulações de espuma e dispositivo para sua entrega
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
IN2014DN08870A (es)
AR091530A1 (es) Formulacion farmaceutica liquida de un anticuerpo y acetato
BR112013029199A2 (pt) sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
MX364652B (es) Formulacion farmaceutica que comprende ciclesonida.
EA201390646A1 (ru) Фармацевтические композиции
PH12015500374A1 (en) Extended release compositions of an aminoalkyl nitrate
EP2939663A4 (en) MELT EXTRUDED PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE AND MEDICAMENT FOR ORAL ADMINISTRATION THEREWITH
NZ702849A (en) Genotype- or phenotype-based drug formulation
MX2017013643A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.
ECSP15005163A (es) Composiciones líquidas orales pediátricas que contienen nepadutant
EA201690395A1 (ru) Стабильная фармацевтическая композиция, содержащая бисопролол и рамиприл

Legal Events

Date Code Title Description
FD Application declared void or lapsed